Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Go back to Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
(NASDAQ: PLRX) Delayed: 1.08 --0 (-0%)
Previous Close $1.08    52 Week High $ 
Open $1.09    52 Week Low $ 
Day High $1.09    P/E N/A 
Day Low $1.07    EPS $ 
Volume 238,681